We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
167 result(s) found, displaying 1 to 10
-
Sep-2025Prescription medicine evaluationActive ingredient: Semaglutide.
-
Prescription medicine registrationActive ingredients: Semaglutide.
-
Australian public assessment report (AusPar)AWIQLI (insulin icodec) has been approved for the treatment, in adults, of type 2 diabetes and type 1 diabetes in conjunction with a bolus insulin, where daily basal insulin injections are not suitable.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRESIBA FLEXPEN insulin degludec 100 U/mL solution for injection multidose cartridge.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Novo Nordisk Pharmaceuticals Pty Ltd - Cartridge-accepting autoinjector, mechanical.
-
Apr-2025Prescription medicine evaluationActive ingredient: Semaglutide.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OZEMPIC 0.25 mg/0.5mg semaglutide (rys) 0.68 mg/mL solution for injection in 3mL pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for REFIXIA nonacog beta pegol 3000 IU powder and solvent for solution for injection.
-
Designation or determinationProvisional determination
-
Prescription medicine registrationActive ingredients: concizumab.